Where does Synaptive Medical (BARBADOS) Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Synaptive Medical (BARBADOS) Inc. ranks #2,202 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Synaptive Medical (BARBADOS) Inc. hold?

Synaptive Medical (BARBADOS) Inc. holds 179 US utility patents granted between 2016 and 2021, spanning 36 technology areas.

What is Synaptive Medical (BARBADOS) Inc.'s Innovation Score?

Synaptive Medical (BARBADOS) Inc. has an Innovation Score of 48.3 out of 100 (top 17% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Synaptive Medical (BARBADOS) Inc. focus on?

Synaptive Medical (BARBADOS) Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 121 patents. Grants appear in 36 CPC subclasses total.

Is Synaptive Medical (BARBADOS) Inc.'s patent grant rate increasing or decreasing?

Synaptive Medical (BARBADOS) Inc.'s recent grant velocity is -50% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Synaptive Medical (BARBADOS) Inc.'s patents?

Synaptive Medical (BARBADOS) Inc.'s patents average 15.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Synaptive Medical (BARBADOS) Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Synaptive Medical (BARBADOS) Inc.

USPTO PatentsView assignee record - 179 granted patents across 36 technology areas, recorded in grant years 2016–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Synaptive ranks #2,202 of 49,997 tracked US assignees by granted-patent volume, with 179 patents across 36 technology areas.

#2,202
of 49,997 US assignees by volume: Top 17%
by Innovation Score (48.3/100): 15.2
avg claims per patent: -50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2202 · Foreign Corporation #2,202 · 179 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 179 grants
TOP-DECILE #2,202/49,997
PHOTO-FINISH Hitachi Energy…
CPC-FOCUS A61B · 36 areas
INNOV-PAR 48.3/100
CLAIMS-RICH 15.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hitachi Energy Switzerland AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Faurecia Autositze · near

48
Kardium · near

48
Kwang Yang Motor · near

48
Synaptive Medical… · this assignee

48
Wright Medical… · near

48
3D Lighting… · lowest

7

What this shows Synaptive's Innovation Score is 48.3/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Synaptive's grants concentrate

Synaptive Medical (BARBADOS) Inc. is a focused PatentsView assignee: 36 CPC subclasses with 67.6% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (58 grants) versus a trough of 2 in 2021. By volume, Synaptive sits between Hitachi Energy Switzerland AG and Brain Corporation.

Hitachi Energy Sw…

179
Inteva Products

179
Katholieke Univer…

179
Kureha

179
Stanley Black & D…

179
The University of…

179
ZF CV Systems Eur…

179
Synaptive Medical… ◀

179
Brain

178

What this shows Synaptive holds 179 patents at rank #2,201, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Synaptive

By rank, the assignees closest to #2,201 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Synaptive's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Synaptive, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (48 here).

Kardium Inc. 48 Wright Medical Technology, Inc. 48 Kwang Yang Motor Co., Ltd. 48 Faurecia Autositze GmbH 48

Similar claim depth

Nearest assignees by average claims per patent (15.2 here).

Indiana University Research AND Technology Corporation 15.2 avg Scott Technologies, Inc. 15.2 avg Outotec (FINLAND) OY 15.2 avg AT&S Austria Technologie & Systemtechnik Aktiengesellschaft 15.2 avg

Synaptive's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 17% higher than 83% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Synaptive Medical (BARBADOS) Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	4	2.2%
2017	28	15.6%
2018	45	25.1%
2019	42	23.5%
2020	58	32.4%
2021	2	1.1%

Which technologies does Synaptive Medical (BARBADOS) Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 121

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 47

G06T - Image Data Processing OR Generation, IN General 43

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 29

H04N - Pictorial Communication, e.g. Television 13

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 13

G06F - Electric Digital Data Processing 11

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; Selection OF Materials FOR Their Magnetic Properties 8

G02B - Optical Elements, Systems OR Apparatus 7

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 7

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 7

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

G01B - Measuring Length, Thickness OR Similar Linear DIMENSIONS; Measuring ANGLES; Measuring AREAS; Measuring Irregularities OF Surfaces OR Contours 6

B25J - MANIPULATORS; Chambers Provided With Manipulation Devices 6

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 6

Top 15 of 36 technology areas

Where it ranks

Overall rank by patents

#2,202

of 49,997 tracked assignees

Innovation Score

48.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Synaptive Medical (BARBADOS) Inc.'s patent record in context - here's where to go next.

Synaptive Medical (BARBADOS) Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 67.6% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #2,202 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Synaptive Medical (BARBADOS) Inc. against Hitachi Energy Switzerland AG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.